| Course | PA 536 Behavioral Medicine II |
|---|---|
| Week | 5 |
| Paper type | Monitoring schedule table |
| Length | About 730 words, 5 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | Master of Physician Assistant Studies (MPAS) |
| Updated | October 2026 |
Free sample paper for PA 536 Week 5
Metabolic Monitoring Schedule for Aripiprazole Added to Fluoxetine in D.K., Who Already Carries a Sensor and a Pump: What Gets Measured, When, Who Starts It and the Line for the Result That Never Arrives
Student Name
Chamberlain University
PA 536: Behavioral Medicine II
Instructor Name
Month Day, Year
Metabolic Monitoring Schedule for Aripiprazole Added to Fluoxetine in D.K., Who Already Carries a Sensor and a Pump: What Gets Measured, When, Who Starts It and the Line for the Result That Never Arrives
Two Kinds of Row
The schedule below follows the 2004 consensus statement on antipsychotics and metabolic risk, which recommends personal and family history, weight, waist circumference, blood pressure, glucose and lipids at baseline, then weight again at weeks 4, 8 and 12 and every quarter after, and the others at 12 weeks and yearly (American Diabetes Association et al., 2004). D.K. already has type 1 diabetes, so some rows are adapted rather than copied.
Table 1
Monitoring Rows for D.K.
| Item | Baseline | Repeats | Who starts it | Same visit or separate trip | Why it is on this schedule |
|---|---|---|---|---|---|
| Weight | June 23 | Weeks 4, 8, 12, then every 3 months | Medical assistant at each visit | Same visit | Aripiprazole can raise weight, and insulin needs rise with it |
| Waist circumference | June 23 | Week 12, then yearly | Medical assistant | Same visit | Central fat tracks cardiovascular risk independently of weight |
| Blood pressure | June 23 | Week 12, then yearly | Medical assistant | Same visit | Diabetes already adds cardiovascular risk |
| Glucose control | A1C on June 23 | A1C every 3 months, as for diabetes care; sensor time in range at every visit | PA reviewing the download | A1C draw with other labs | Already monitored; the schedule adds a question about change since the drug started |
| Lipids | June 23, nonfasting | Week 12, then yearly | PA orders; lab draws | Separate lab trip unless drawn at visit | Weight gain can raise triglycerides and lower HDL |
| Restlessness check | June 23 | Week 1 call, week 2 and week 4 visits | Nurse, then PA | Same visit or phone | The side effect most likely to end the plan |
Note. Note. Baseline weight 78.4 kg, waist 91 cm, blood pressure 124/78 mm Hg, A1C 7.9 percent, all on June 23.
A Reason on Every Line
Each row carries its reason because rows without reasons tend to be dropped first when a visit is busy. The glucose row is the clearest example of adapting a general schedule to a person: a fasting glucose, the measure the consensus names, says almost nothing in someone on insulin with a sensor reading every five minutes. The useful question is whether time in range, insulin totals or A1C change after aripiprazole starts, and the PA reviewing the download is the person who can see that.
Nonfasting by Design
The lipid panel is drawn nonfasting. For someone on an insulin pump, fasting before an early lab draw adds a risk of lows and often means a missed shift. Current cholesterol guidance accepts a nonfasting lipid profile for most baseline risk assessment (Grundy et al., 2019). If triglycerides come back high on a nonfasting sample, a fasting repeat can be arranged on a day off.
Somebody Starts It
Every row names who starts it. Weight, waist and blood pressure are taken by the medical assistant at check-in, since they cost nothing extra. Labs are ordered by the PA at the visit before they are due, so the order is waiting at the lab. The restlessness questions belong to the nurse at week 1 and the PA after that.
The Line for the Missing Result
In a general clinic the commonest result is a missing one. If the week 12 lipid panel has not been drawn by week 14, the front desk sees a flag at D.K.'s next check-in and the draw is done that day. The result is written in the chart as "not obtained, reason," not left blank, so the next clinician can tell an overlooked test from a declined one.
Can This Person Get There
D.K.'s dispatch shift starts before dawn and ends in the early afternoon. The lab is open until 4:00 p.m. on weekdays and has no weekend hours. Every lab draw is therefore planned for an afternoon visit or for the same trip as a diabetes appointment, which D.K. already makes every three months. No row requires a morning appointment.
References
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2), 596-601. https://doi.org/10.2337/diacare.27.2.596
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., . . . Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 139(25), e1082-e1143. https://doi.org/10.1161/CIR.0000000000000625
The Chamberlain PA 536 Week 5 instructions
The fifth week asks for a monitoring schedule for a medicine that carries metabolic risk, usually an antipsychotic. Most sections want it as a table in which every row states what is measured, when at baseline and when it repeats, who initiates it and why it belongs on this person's schedule. Items that can be done at an ordinary visit, such as weight, waist and blood pressure, should be kept visibly apart from those that need a separate trip or fasting. The instructions also ask what happens when a result is missing, which is the commonest outcome in general practice, and whether the person can realistically reach the lab when the schedule says so. Where the person's existing conditions make a standard row meaningless, adapt it and say why. Cite the monitoring recommendation the schedule is built on.
How the PA 536 Week 5 example is put together
A short opening cites the 2004 consensus (American Diabetes Association et al., 2004) and notes that D.K.'s diabetes means some rows will be adapted. The table has six rows: weight at weeks 4, 8 and 12 and then quarterly; waist and blood pressure at week 12 and yearly; glucose control through A1C every three months and sensor time in range at every visit; nonfasting lipids at week 12 and yearly; and restlessness checks at week 1, 2 and 4. Each row names an initiator and says whether it happens at a visit or needs a trip. A table note gives baseline values: 78.4 kg, 91 cm, 124/78 and an A1C of 7.9. Later sections explain why fasting glucose is useless on a pump, why lipids are nonfasting (Grundy et al., 2019), who starts each row, how a missed draw is flagged at week 14 and why every draw is in the afternoon.
Reading the PA 536 Week 5 grading rubric
In this schedule the costliest flaw is assuming every row will happen. A table with no plan for a missing result has not been built for a general clinic, and graders deduct the most for it. Rows justified only by habit, with nothing tying them to this person, lose the next share. Faculty then check each row for an initiator; a measurement nobody is assigned to start tends not to happen. Baseline and repeating entries must be distinguishable at a glance. Separating same-visit items from separate-trip items earns credit because it shows where the plan is fragile. Adapting a standard row to the person's existing conditions, with a stated reason, is rewarded. Checking whether the person can reach the lab when the schedule says, and citing the consensus or guideline the schedule follows, complete the rubric.
Common PA 536 Week 5 mistakes, and how to avoid them
Copying the consensus table into a page and calling it a schedule is the usual mistake: the intervals are right, but no one is assigned, the missing result has nowhere to go and fasting labs are booked at hours the person works. Another error is keeping a fasting glucose row for someone whose diabetes is already monitored more closely. If your course patient takes a different agent, such as olanzapine or quetiapine, or has no diabetes, send the scenario and the format your section wants; our version would set each row with its timing, initiator, setting and reason, add the line for results that never arrive and check the plan against the person's working hours and transport. Mention any rows your faculty ask for beyond metabolic ones, such as prolactin or movement checks, and they will be built in with their own reasons.
Get a PA-536 Week 5 example written to your instructions
Send the assignment, the rubric, any grid or table your section requires and the case it issued, and say whether the schedule is meant to stand alone or sit inside a longer document. A custom PA-536 Week 5 schedule is written into that format and returned inside 24-48h, the first one free.
More PA 536 papers and MPAS samples
- PA 536 Week 1: Treatment Target Post
- PA 536 Week 2: Antidepressant Selection Memo
- PA 536 Week 3: Antidepressant Trial Appraisal
- PA 536 Week 4: Switch Versus Augment Brief
- PA 536 Week 6: Therapy Modality Brief
- PA 536 Week 7: Medical Comorbidity Review
- PA 536 Week 8: Maintenance and Taper Plan
- PA 534 Week 5: Milestone Screening Write-Up
- PA 533 Week 5: Maternal-Fetal Risk Brief
- PA 532 Week 5: Procedure Step Sequence
- PA 531 Week 5: Stabilization Sequence Write-Up
PA 536 Week 5 questions, answered
Our assignment does not name the treatment being monitored.
Then write the schedule against the class of parameters the week covers and say once, near the top, what the schedule is assuming. Sections that leave the agent open are usually marking whether you can justify intervals and assign initiators rather than whether you matched a reference. Send what your instructions actually say and the example is built to that level of specification instead of inventing one.
Does the schedule include what the person does at home?
Yes wherever the assignment calls for it, and those rows obey the same rule as the rest: a measurement, a timing, and somebody responsible. Keep them visibly separate from the rows the clinic owns, since a reader needs to know at a glance which lines depend on somebody remembering. Anything the person is asked to bring to the next appointment belongs written as an instruction rather than as an expectation.
Can a row say that nothing is checked for now?
It can, and a schedule with a defended empty period reads as considered rather than thin. Say what is not being measured over the coming stretch and why that is reasonable here, then name what would put it back. What graders penalize is the silent version, where a parameter the week covers simply never appears and a reader cannot tell whether it was decided against or forgotten.
Where can I find a free PA 536 Week 5 sample paper?
This page holds a full PA 536 Week 5 metabolic monitoring schedule for aripiprazole in a patient with type 1 diabetes, with six rows and a plan for missing results.
Why are lipids drawn nonfasting in the PA 536 Week 5 sample?
Fasting before an early draw risks lows on an insulin pump and costs a shift, and current cholesterol guidance accepts a nonfasting panel for most baseline assessment.